Columbus, OHNCT06815471Now EnrollingIRB Ready

Worsening Heart Failure Clinical Trial in Columbus, OH

Access cutting-edge worsening heart failure treatment through this phase 2 clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.

Sponsored by Corteria Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Columbus location

Preparing your pre-screening questions…

Expert Care in Columbus

Access worsening heart failure specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related worsening heart failure treatment provided free

Apply for This Columbus Location

Check if you qualify for this worsening heart failure clinical trial in Columbus, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Columbus

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Columbus site if eligible
  4. 4Begin participation

About This Worsening Heart Failure Study in Columbus

This study assesses the effects of the investigational drug COR-1167 in subjects hospitalised due to worsening of heart failure (HF)

Sponsor: Corteria Pharmaceuticals

Who Can Participate

Inclusion Criteria

Signed written informed consent
Previous diagnosis of HF documented in source records and confirmed by investigator assessment (no historical written documentation required)
Prescribed an oral loop diuretic for at least 1 month preceding the index event
NT-proBNP ≥300 pg/mL or BNP ≥100 pg/mL
Requires treatment with i.v. diuretics for volume overload
At least 1 risk factor for diuretic resistance
Admitted to the hospital not more than 120 hours prior to randomization

Exclusion Criteria

Index event primarily triggered by an acute event (e.g. AMI, PE, arrhythmia)
Administration of i.v. inotropic therapy or i.v. vasodilators, use of mechanical ventilation, high-flow oxygen therapy, or NIV prior to randomization
Requirement for, or planned use of LVADs, IABP, or any type of MCS
History of solid organ transplant or active on a transplant list
SBP \<100 mmHg
eGFR \< 20 mL/min/1.73 m2
CABG, PCI, implantation of CRT, heart valve procedure or any cardiac surgery within 1 month prior to screening or planned during the study
Severe stenotic cardiac valvular disease
Severe chronic pulmonary disease requiring chronic steroid therapy or chronic oxygen therapy (\> 2 L/min)
Uncorrected severe hyperthyroidism or hypothyroidism
Severe restrictive, obstructive, or infiltrative cardiomyopathy
Body weight \< 70 kg at screening
Use of any investigational drug(s) within 5 half-lives of screening
At high risk of death, defined as life expectancy ≤1 year (such as participants in potential impending cardiogenic shock), or any disease that, in the opinion of the Investigator, will preclude their safe participation in this study, and will make implementation of the protocol or interpretation of the study results difficult
Presence of any other conditions (e.g. geographic, social) actual or anticipated, that the Investigator feels would restrict or limit the subject's participation or compliance with all study procedures
Participant is the Investigator or any Subinvestigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the study
Increased lactate levels \> upper limit of normal (local laboratory) at screening
Severe chronic liver disease (such as cirrhosis)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Columbus?

Yes, this clinical trial (NCT06815471) has an active research site in Columbus, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Worsening Heart Failure Treatment Options in Columbus, OH

If you're searching for worsening heart failure treatment options in Columbus, OH, this clinical trial (NCT06815471) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Columbus research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced worsening heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all worsening heart failure clinical trials near you to find additional studies recruiting in your area.

More Heart Failure Trials in Columbus, OH

See all heart failure clinical trials recruiting in Columbus — not just this study.

Browse Heart Failure Trials in Columbus →

Ready to Join in Columbus?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Columbus, OH